Kraig Biocraft Laboratories (KBLB) Notes Payables (2016 - 2025)

Kraig Biocraft Laboratories has disclosed Notes Payables across 10 years of filings, most recently posting $1.5 million for Q4 2025.

• Notes Payables for Q4 2025 came in at $1.5 million, down 7.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 7.73% YoY), and the FY2025 annual result was $1.5 million, down 7.73% from the prior year.
• Notes Payables came in at $1.5 million for Q4 2025 at Kraig Biocraft Laboratories, down from $1.6 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $6.3 million in Q3 2023 to a low of $285997.0 in Q1 2021.
• The 5-year median for Notes Payables is $1.6 million (2022), against an average of $2.1 million.
• Across the five-year window, Notes Payables jumped 465.39% in 2022 and plunged 74.19% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Notes Payables stood at $503423.0 in 2021, then surged by 221.2% to $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then slipped by 7.73% to $1.5 million in 2025.
• The last three Notes Payables figures came in at $1.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.